Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002038627 | SCV002312784 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with leucine at codon 476 of the AIRE protein (p.Ser476Leu). The serine residue is highly conserved and there is a large physicochemical difference between serine and leucine. This variant is present in population databases (rs754217318, ExAC 0.006%). This variant has not been reported in the literature in individuals affected with AIRE-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C65"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004976187 | SCV005580154 | uncertain significance | Inborn genetic diseases | 2024-11-09 | criteria provided, single submitter | clinical testing | The c.1427C>T (p.S476L) alteration is located in exon 12 (coding exon 12) of the AIRE gene. This alteration results from a C to T substitution at nucleotide position 1427, causing the serine (S) at amino acid position 476 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |